Pioneers in advancing care for all hematologic cancers and other blood-related disorders, City of Hope's Department of Hematology and Hematopoietic Cell Transplantation is a leader in setting standards for treatment worldwide and in improving long-term outcomes for both children and adults.
City of Hope combines important research discoveries with superior clinical techniques to diagnose, evaluate and provide the most advanced treatments for
City of Hope leads the field of hematopoietic cell transplantation (HCT) as one of the world’s largest and most successful transplant centers.
HCT is also useful in treating other cancers such as breast cancer and ovarian cancer, as well as noncancerous conditions such as inherited disorders of the bone marrow and autoimmune diseases such as scleroderma.
Our renowned multidisciplinary team is comprised of nationally recognized experts in the care of patients with these disorders.